BETA vs LUNR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BETA Technologies exhibits weak financial health per the Piotroski F-Score of 4/9, indicating a fragile operational foundation despite strong revenue growth. The company's profitability metrics are severely impaired, with a negative operating margin of -1210.42% and a negative ROE of -66.19%, signaling deep operational inefficiencies. Although the firm shows robust revenue growth (150.90% YoY) and a high gross margin (72.20%), these are not translating into earnings or cash flow. The absence of a Graham Number and intrinsic value, combined with a forward P/E of -6.24, reflects a market pricing premium based on speculative growth rather than fundamentals. The lack of analyst consensus on target price and neutral insider activity further undermine conviction.
LUNR exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -3.92. While the stock has experienced a speculative price surge, the underlying financials show declining revenue growth (-18.10% YoY) and deep operating losses. The absence of a Graham Number or Altman Z-Score reflects a balance sheet that cannot support traditional valuation models. With heavy insider selling and a technical trend turning bearish, the current price appears decoupled from intrinsic value.
Compare Another Pair
Related Comparisons
BETA vs LUNR: Head-to-Head Comparison
This page compares BETA Technologies, Inc. (BETA) and Intuitive Machines, Inc. (LUNR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.